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Abstract
Background: Cellular differentiation programs are controlled, to a large extent, by the combinatorial functioning of
specific transcription factors. Cortical projection neurons constitute the major excitatory neuron population within
the cortex and mediate long distance communication between the cortex and other brain regions. Our understanding
of effector transcription factors and their downstream transcriptional programs that direct the differentiation process of
cortical projection neurons is far from complete.
Results: In this study, we carried out a ChIP-Seq (chromatin-immunoprecipitation and sequencing) analysis of
NEUROD2, an effector transcription factor expressed in lineages of cortical projection neurons during the peak of
cortical excitatory neurogenesis. Our results suggest that during cortical development NEUROD2 targets key
genes that are required for Reelin signaling, a major pathway that regulates the migration of neurons from
germinal zones to their final layers of residence within the cortex. We also find that NEUROD2 binds to a large set
of genes with functions in layer-specific differentiation and in axonal pathfinding of cortical projection neurons.
Conclusions: Our analysis of in vivo NEUROD2 target genes offers mechanistic insight into signaling pathways
that regulate neuronal migration and axon guidance and identifies genes that are likely to be required for proper
cortical development.
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Background
The neocortex is a six-layered structure composed of myr-
iad excitatory and inhibitory neuron types. Developmental
programs, controlled by multiple cell-intrinsic and –ex-
trinsic cues, establish unique patterns of connectivity for
the diverse neuronal subtypes located in different layers.
While the granular neurons of layer IV form networks of
local connections within cerebral hemispheres, projection
neurons of layers II/III, V and VI mediate long distance
communications both within and outside the cortex.
Developmentally, excitatory neurons are born from div-
iding progenitors located in distinct germinal domains sit-
uated at ventricular and subventricular zones of the dorsal
telencephalon. Once born, they migrate to superficial cor-
tical layers, with each wave of migrating neurons surpass-
ing predecessors, resulting in six distinct cortical layers
generated in an inside-out manner [1]. Consequently,
birthdate of a neuron determines its final layer of resi-
dence and confers its layer-specific properties. During and
following migration, cortical projection neurons initiate
expression of specific sets of axon guidance molecules that
allows pathfinding to correct targets [2]. The end product
of this highly complex and regulated migration and axon
guidance process is a neocortex organized into six layers,
with neurons residing in each layer exhibiting unique
physiological properties and patterns of connectivity [3].
Almost all aspects of neurogenesis, migration and neuronal
differentiation are orchestrated by hierarchical and combina-
torial functioning of transcription factor (TF) networks [4].
* Correspondence: gdunn@ku.edu.tr
†Equal contributors
1Molecular Biology and Genetics Department, Koç University, Rumeli Feneri
Yolu, Istanbul 34450, Turkey
Full list of author information is available at the end of the article
© 2015 Bayam et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Bayam et al. BMC Genomics  (2015) 16:681 
DOI 10.1186/s12864-015-1882-9
Within the embryonic germinal zones, expression of Neu-
rog1 and Neurog2 proneural basic helix loop helix (bHLH)
transcription factors commit neural progenitors to cortical
excitatory neuron identity [5, 6]. NEUROG2 is both neces-
sary and sufficient for generation of these neurons [7] and
NEUROG2 initiated specification of projection neuron
identity involves a complex transcription factor network
composed of effector transcription factors, such as TBR1
(T-box brain 1), NEUROD1 (Neuronal differentiation 1)
and NEUROD2 (Neuronal differentiation 2) [7–9].
Despite our relatively thorough understanding of the TFs
required for specifying a cortical excitatory neuron identity,
little is known about how differentiation programs are
executed by effector TFs and the nature of the downstream
target genes required for corticogenesis. For example,
Neurod2 is expressed within a wide temporal window
(from embryonic day 10.5 throughout adulthood) outside
of the proliferative zones and constitutes a potential regu-
lator of critical aspects of differentiation and/or mainten-
ance of different types of cortical excitatory neurons
[8, 10]. Indeed, several studies investigating the conse-
quences of NEUROD2 loss-of-function in mice have dem-
onstrated that NEUROD2 is required for commissural
axon pathfinding of layer II/III callosal projection neurons,
formation of cortical somatosensory maps within layer IV
granular neurons and maturation of dendrites and synap-
ses in the hippocampus [11–13]. Furthermore, a gain-
of-function study has demonstrated that misexpression of
Neurod2 in ventral telencephalon progenitors is sufficient
to prevent their normal GABAergic differentiation [14].
Although during development NEUROD2 controls the
execution of a wide range of functions, its target genes dur-
ing cortex development are largely unknown. In this study
we identified genome-wide targets of NEUROD2 during
mid-embryogenesis. We demonstrate that NEUROD2
binds to a large number of target genes with prominent
roles in radial migration, layer-specific differentiation and
axon pathfinding of cortical projection neurons. Moreover,
we find that NEUROD2 is positioned to control cortical
radial migration by regulating members of the Reelin
signaling pathway. Importantly, we demonstrate that
expression of Cdk5r1, the regulatory subunit of cyclin-
dependent kinase 5, is critically dependent on NEUROD2.
Our identification of NEUROD2 targets offers mechanistic
insight into known and potentially novel functions of this
effector transcription factor and points to the importance
of carrying out ChIP-Seq analysis at developmental time-
points within relevant tissue.
Results and discussion
Identification of NEUROD2 binding sites in embryonic
cortex
In mice, the bulk of cortical excitatory neurogenesis takes
place during the last ten days of gestation, a period which
also coincides with high levels of Neurod2 expression
[10, 15]. Therefore, in order to determine the genome-
wide targets of NEUROD2 during cortical development,
we carried out chromatin-immunoprecipitation followed
by high-throughput sequencing (ChIP-Seq) (Fig. 1b). First,
we identified three antibodies that could successfully im-
munoprecipitate NEUROD2 following overexpression in
Neuro2A cell line (Additional file 1). After isolating
NEUROD2-associated chromatin from mouse embryonic
day 14.5 (E14.5) cortex, we confirmed that the promoter
region of the Nhlh2 gene, a previously identified
NEUROD2 target [16], was amplified by PCR using ChIP
template DNA precipitated by all three NEUROD2 anti-
bodies, but not from ChIP DNA prepared by an unrelated
antibody against GFP (Fig. 1a). After massively parallel se-
quencing of all three NEUROD2 ChIP DNA and two sep-
arate GFP ChIP DNA samples, we mapped reads using
Bowtie short read aligner [17, 18]. NEUROD2 peaks were
identified by MACS (Model-based analysis of ChIP-Seq)
[19] and GFP peak alignments were used as input control
dataset for signal normalization (cutoff p-value of < 10−5).
From the three experimental samples a total of approxi-
mately 32,900,000 unique reads were identified, which
mapped onto 94,621 peaks (Additional file 2).
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Fig. 1 ChIP-Seq reveals NEUROD2 target genes during cortical
development. a Chromatin DNA was immunoprecipitated with three
different antibodies against NEUROD2 (ab1, ab2 or ab3) or with a GFP
antibody which was used as a negative control. PCR was performed
using immunoprecipitated DNA as template. Specific primers amplified
the promoter region of a previously identified NEUROD2 target gene
Nhlh2 [16]. An enrichment for the positive control Nhlh2 gene was
demonstrated in NEUROD2 ChIP-PCR samples as compared to GFP
ChIP-PCR. b The developing cortex (dorsal telencephalon) was
dissected from E14.5 mouse brain and used for NEUROD2 ChIP-Seq.
32,367 peak regions and 1,045 target genes were identified
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The quality of our data was validated by the high degree
of correlation among the three NEUROD2 antibodies
(Pearson’s correlation coefficient R2 values: ab1 and ab2:
0.89; ab1 and ab3: 0.75; ab2 and ab3: 0.84). In contrast,
comparison of NEUROD2 peaks generated by the three
individual antibodies to those of another transcription fac-
tor expressed in the mouse embryonic brain, CTCF, re-
sulted in much lower R2 values (ab1 and CTCF ab: −0.16;
ab2 and CTCF ab: −0.18; ab3 and CTCF ab: −0.21). In an
effort to reduce false-positive binding sites due to non-
specific interactions of the particular antibody used, we
decided to discard peaks that are identified in only one of
the three ChIP-Seq datasets acquired using the three sep-
arate antibodies. As a result, out of a total of 94,621 peaks
from three separate datasets, 72,871 peaks were found to
be located in regions containing overlapping peaks from
at least two antibodies. Next, we collapsed all the overlap-
ping peaks to obtain the union of peak coordinates and as
a result identified 32,367 NEUROD2 binding locations.
Following analyses were carried out using these 32,367
NEUROD2 binding sites (Additional file 3).
Neuronal bHLH transcription factors like NEUROD2
bind to an E-box motif, which is loosely defined as
CANNTG [20–22]. Therefore, we asked whether or not
the NEUROD2 peak sequences were enriched in E-box
elements. By using the MEME-CHIP Suite [23], a tool
designed to identify enriched sequence elements in large
datasets, we discovered that an extended E-box motif,
CA(G/T)(C/A)TG(G/T), was significantly associated
with NEUROD2 peak sequences (Fig. 2a).
In order to determine NEUROD2 binding preference
along the genome and therefore gain insight into its
mechanism of action, we examined peak positions relative
to annotated transcriptional units. Analysis of all 32,367
sites revealed that approximately half of NEUROD2 bind-
ing locations (45 %) mapped onto annotated Ensembl
transcripts (mm10 build) [24] and the remainder mapped
onto intergenic regions. Within a gene, 83 % of intragenic
sites were associated with intronic regions and 17 % were
associated with 5′UTR, coding (CDS), or 3′UTR exons
(Fig. 2b). However, on average introns are ~25–30 times
longer than exons [25], therefore in order to normalize for
this length bias we calculated the probability of binding
along a gene compared to a random distribution profile.
Our calculations revealed that NEUROD2 binding was
most likely to be embedded in the first 5′UTR exon
with an approximately 8-fold enrichment in probability
compared to random distribution (p-value = 1 × 10−2132)
(Fig. 2c). Next, we generated a NEUROD2 binding map
relative to annotated transcription start sites (TSSs) and
observed a major accumulation of NEUROD2 peaks
within 1000 bps from a TSS (Fig. 2d). Therefore, in vivo
NEUROD2 preferentially binds to TSS proximal se-
quences located within or upstream of 5′UTR exons.
A previous study used a ChIP-Seq approach to investi-
gate genome-wide targets of NEUROD2 after its viral
transduction into the P19 cell line [16]. However, since
this study was conducted in cell culture, it may not pro-
vide an accurate reflection of the in vivo targets of NEU-
ROD2 during cortex development. In fact, recent studies
propose that transcription factor-chromatin associations
are context dependent and can vary between developmen-
tal stages and tissue types [26–28]. Therefore, within the
context of cortical development, with the exception of a
small number of candidate genes studied so far, NEU-
ROD2’s genome-wide targets and the kinds of biological
processes regulated are largely unknown [11–13]. Since
our data demonstrate that NEUROD2 binding was not ex-
clusive to promoter regions or TSS-proximal sequences,
we decided to employ a method for assigning individual
peaks to genes which would also account for TSS-distant
peaks, as opposed to methods which set fixed windows
around TSSs for peak capturing. For this reason, we de-
cided to use the ClosestGene method which assigns scores
to individual genes based on the number of associated
peaks and their proximity to respective transcription start
sites [29]. We calculated two scores for each gene in the
mouse genome by using either the 32,367 NEUROD2
peaks or the same number of randomly distributed peaks
as the input dataset. Plotting the distribution profiles of
the scores calculated by NEUROD2 peaks or random
peaks revealed a very significant difference between these
two datasets (p-value ~ 0) (Fig. 2e). Next, we calculated a
normalized ClosestGene score for each gene by simply
subtracting the random score from the NEUROD2 score
(Additional file 4). We then selected putative target genes,
with varying scores, for confirmation by NEUROD2 ChIP
followed by quantitative PCR (qPCR) using the immuno-
precipitated DNA as template. We selected genes from
the top 1,045, representing genes whose scores were above
one standard deviation (σ) of the mean and were able to
confirm 10 out of 11 (Fig. 2f and Additional file 5). In
addition, as negative controls we tested 5 genes (Gsx2,
Dlx2, Npy, Gad1 and Calb2) which were not identified as
NEUROD2 targets (i.e., non-targets). These five genes are
expressed in interneurons and not in Neurod2-expressing
cortical projection neurons. We did not observe any sig-
nificant enrichment in NEUROD2 binding to 4/5 of the
non-target genes and only a slight enrichment in Gsx2, a
finding worthy of future investigation (Additional file 5).
In sum, in light of our high confirmation rate of NEU-
ROD2 binding to putative target genes we decided to use
the top 1,045 in all further analyses.
NEUROD2 target genes are associated with radial
migration of cortical neurons
To further gain broad understanding into the biological
processes regulated by NEUROD2 we carried out gene
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ontology analysis. We identified significantly over-rep-
resented biological processes in the top 1,045 targets
against all of the genes in the mouse genome. Ranking
based on fold enrichment of biological processes above a
significance threshold (p-value < 10−3), revealed that the
highly ranked NEUROD2 controlled activities broadly
converged onto two major developmental processes;
cortical radial migration and axon guidance/fascicula-
tion (Table 1).
To gain further understanding of the signaling path-
ways that were regulated by NEUROD2, we carried out
pathway analysis with the NEUROD2 target genes





Fig. 2 NEUROD2 binds to E-box elements proximal to TSSs in vivo. a NEUROD2 consensus sequence was predicted using 32,367 peak regions
as input for the MEME-ChIP suite [23]. b Among the 32,367 NEUROD2 peaks, approximately 45 % mapped onto Ensembl annotated genes
(mm10 reference genome) [24, 55]. Among them approximately 83 % mapped onto introns, and 17 % to either 5′UTR, CDS or 3′UTR exons. c
The binding preference of NEUROD2 to introns, 5′UTR exons, 3′UTR exons and CDS exons was calculated. The number of NEUROD2 binding
sites observed on introns (red), 5′UTR (green), 3′UTR (blue) and CDS (purple) exons were normalized to the length of each of these gene seg-
ments and compared to a random distribution profile (grey bar). The data suggests approximately an 8-fold enrichment in NEUROD2 binding
to the first 5′UTR exon, a 5-fold enrichment in binding to the first CDS exon and approximately 2-fold enrichment in binding to the first and
second 3′UTR exons. ***p-value ~ 0, *p-value < 0.001. d A binding map of NEUROD2 relative to closest TSSs, revealed that NEUROD2 has a
binding preference within +/− 1000 bps of TSSs. Peaks that mapped upstream (blue) and downstream (red) of TSSs are color-coded.
e The distribution profiles of ClosestGene scores [29] calculated by using NEUROD2 peaks (blue) were very significantly different from those
calculated using randomly distributed peaks (red) on the genome (***p-value ~ 0). f Distribution of normalized scores for individual genes were
generated by subtracting the ClosestGene score calculated using NEUROD2 peaks from that of random peaks. Dark green represents genes
whose scores were greater than one standard deviation (σ) above the mean and were used for further analyses
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we identified Reelin Signaling as the most significantly
targeted pathway (p-value: 4.7 × 10−3) (Additional file 6).
The REELIN protein is secreted by the Cajal-Retzius
cells, located on the surface of the developing cortex. By
binding to receptors on migrating cortical neurons,
REELIN promotes reorganization of the cytoskeleton
and regulates neuronal migration (Fig. 3a) [1, 30]. Our
analysis revealed that NEUROD2 targets included sev-
eral key members of this pathway, such as Fyn, Cdk5r1,
Dab1 and Lrp8 (ApoE Receptor 2) genes (Fig. 3a).
We next focused our analysis on two important regula-
tors of cortical radial migration, Cdk5r1 and Lrp8 genes.
Initially, examination of expression patterns at mid-
embryogenesis (E15.5) revealed that Neurod2 expression
largely overlapped with zones of Lrp8 and Cdk5r1 expres-
sion (Allen Developing Mouse Brain Atlas, Fig. 3c, d and
e). Next, we examined whether NEUROD2 binding along
Cdk5r1 and Lrp8 genes were associated with enhancer or
promoter regions. We acquired ChIP-Seq data from E14.5
whole brain for H3K4me1 histone modification as a
marker for enhancer regions and H3K4me3 modification
as a marker for promoter regions [31] (www.encodepro-
ject.org). Overlaying of these datasets with NEUROD2
peaks revealed that NEUROD2 binding was associated
with both promoter and enhancer specific histone marks
on these two genes (Fig. 3f and i). We further confirmed
NEUROD2 association with the promoter regions of Lrp8
and Cdk5r1 genes by NEUROD2 ChIP followed by qPCR
(Fig. 3g and j). Finally, we asked whether NEUROD2 con-
trols Cdk5r1 and Lrp8 transcription. We knocked down
Neurod2 expression almost completely in primary cortical
neurons by high-efficiency transfection of small hairpin
RNA (Fig. 3b). Remarkably, our RT-qPCR results demon-
strated a significant, five-fold reduction in Cdk5r1 mRNA
levels after Neurod2 knockdown, as compared to a control
sample transfected with a non-targeting shRNA (Fig. 3h).
Lrp8 mRNA also exhibited a trend in reduction in NEU-
ROD2 lacking neurons, however with lower significance
(Fig. 3k). In sum, our results strongly support NEUROD2
control of radial migration and the Reelin signaling path-
way through direct regulation of key genes such as Cdk5r1
and Lrp8.
Next, we asked whether NEUROD2 was expressed in
neurons of the intermediate zone (IZ), which is a devel-
opmentally transient cortical region through which
post-mitotic neurons born in subventricular (SVZ) and
ventricular (VZ) zones migrate in order to reach their final
destination within the cortical plate (CP) [32]. To mark
neurons that have completed their migration and are lo-
calized to the cortical plate, we performed co-staining with
antibodies against the TBR1 transcription factor and NEU-
ROD2. As expected, we identified NEUROD2+/TBR1+
neurons localized to the CP (Fig. 4a). In addition, a large
fraction of NEUROD2+ neurons were localized within the
IZ, below the layer of TBR1+ CP, most likely constituting
the migratory population. Taken together, our results are
consistent with a model in which NEUROD2 expression
is initiated in post-mitotic neurons right before the onset
of migration and regulates a set of genes, that includes
critical components of the Reelin pathway.
Next, in an unbiased approach to identify probable
gene candidates regulating migration through the IZ, we
asked whether the expression of a particular set of NEU-
ROD2 targets were enriched in the neurons of this zone.
Towards this goal, we took advantage of a study describing
differentially expressed transcripts by laser capture micros-
copy followed by mRNA-SEQ within three major regions
of the E14 cortex; cortical plate (CP), subventricular-
intermediate zones (SVZ-IZ) and ventricular zone (VZ)
[33]. In this study, each differentially expressed gene
(DEG) was categorized as being strictly specific to one
zone (CP, SVZ-IZ and VZ), or as being expressed in two of
the three zones (CP∩SVZ-IZ and SVZ-IZ∩VZ). A compari-
son of NEUROD2 targets with the expression profiles of
DEGs revealed that approximately 35 % of all SVZ-IZ spe-
cific genes (representing 18 genes in total) were also targets
of NEUROD2 (p-value < 0.05) (Fig. 4b and Additional file
7). This comparison revealed lower percentages for the
other four categories. For example, in the VZ where post-
mitotic neurons are excluded and cell division of progeni-
tor neurons takes place, only 6 % of DEGs were also targets
of NEUROD2. The overlap between DEGs in any category
and equivalent numbers of randomly selected genes from
the mouse genome was approximately 3 % (Fig. 4b). Con-
sistent with known functions of previously identified genes
that are required for radial migration, the functions of the
18 SVZ-IZ specific NEUROD2 targets converged on axon
guidance, regulation of neuronal polarity and actin cyto-
skeleton (Additional file 7) [1]. Taken together, our
Table 1 Gene Ontology Analysis of NEUROD2 targets
Biological process Fold enrichment p-value
Neuron projection guidance 3.61 3.36 × 10−08
Axon guidance 3.56 8.24 × 10−04
Forebrain neuron differentiation 3.15 1.53 × 10−04
Forebrain cell migration 2.93 4.91 × 10−08
Central nervous system
neuron development
2.91 6.79 × 10−06
Cerebral cortex cell migration 2.88 2.81 × 10−09
Telencephalon cell migration 2.86 1.12 × 10−07
Cerebral cortex radially
oriented cell migration
2.75 3.3 × 10−05
Axon fasciculation 2.69 7.55 × 10−18
Neuron recognition 2.69 7.55 × 10−18
Biological process categories above a cutoff p-value (<1 × 10−3) are ranked by
fold enrichment. Fold enrichment is calculated as log2(observed/expected)
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Fig. 3 (See legend on next page.)
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combined data strongly support a role for NEUROD2 in
radial migration of cortical neurons.
NEUROD2 is positioned to control differentiation and
axonal guidance of distinct cortical projection neuron
lineages
Neurons that are migrating through the IZ during mid-
embryogenesis differentiate into different types of cortical
projection neurons [15]. The genetic programs that specify
the identities of distinct cortical projection neuron lineages
are only partially understood. Loss-of-function studies of a
set of layer-specific transcription factors have unveiled
their requirement for distinct axon guidance programs and
establishment of lamina-specific connectivity [2, 34–38].
Interestingly, we noticed the presence of such a group of
transcription factors that control the differentiation of
layer-specific properties of cortical projection neurons in
our NEUROD2 target gene dataset. We identified that
both deep layer markers, such as Fezf2 and Bcl11b (Ctip2)
and upper layer markers such as Cux1 and Satb2 scored
highly in our NEUROD2 target gene list (Additional file 4).
Analysis of NEUROD2 peaks that mapped onto the
genetic loci of Fezf2, Bcl11b, Cux1 and Satb2 uncovered
association at several distinct points which overlapped
with enhancer (H3K4me1) and promoter (H3K4me3)
specific histone marks (Fig. 5b, f, j and n). Examination
Fig. 4 NEUROD2 target genes are enriched in the subventricular-intermediate zone of the developing cortex. a Immunofluorescent staining against
NEUROD2 and TBR1, and DAPI staining on coronal sections prepared from E14.5 mouse brain. NEUROD2 positive neurons are observed in the SVZ-IZ
region of the developing cortex. Scale bar, 62 μm. b The percentage of overlap between NEUROD2 target genes and differentially expressed genes
(DEGs) in the cortical plate (CP), subventricular zone/intermediate zone (SVZ-IZ), ventricular zone (VZ), and those that are preferentially expressed in
two regions (CP∩SVZ-IZ and SVZ-IZ∩VZ) are plotted. NEUROD2 target genes (in blue) display an enrichment in DEGs of the different cortical regions
(in particular the SVZ-IZ region) as compared to randomly selected genes (in red) from the mouse genome
(See figure on previous page.)
Fig. 3 NEUROD2 targets Cdk5r1 and Lrp8 genes during corticogenesis. a Diagrammatic representation of the Reelin signaling pathway that is
required for cortical radial migration. Genes that are targets of NEUROD2 are marked with a red star. b NEUROD2 western blotting confirms
knockdown in primary cortical neuronal culture transfected with Neurod2 shRNA as compared to a non-targeting shRNA. EGFP is used to verify
transfection efficiency and BETA-ACTIN is used as a loading control. c, d and e mRNA expression data is obtained from Allen Developing Mouse
Brain Atlas (http://developingmouse.brain-map.org) for Neurod2, Cdk5r1 and Lrp8 genes in E15.5 mouse brain. f and i NEUROD2 peaks associated
with Cdk5r1 and Lrp8 are plotted relative to enhancer (H3K4me1) and promoter (H3K4me3) marks. H3K4me1 and H3K4me3 ChIP-Seq data is from
(www.encodeproject.org) [31]. Peaks are plotted using the genome browser at genome.ucsc.edu. g and j NEUROD2 ChIP followed by qPCR
confirms NEUROD2 binding to the promoter regions of Cdk5r1 and Lrp8 relative to a negative control (GFP ChIP). Data is normalized to the
amount of input DNA as described in the Methods section (p-value < 0.05). Bars represent standard error of mean. Data represents two biological
and five technical replicates. h and k Reverse transcription and qPCR analysis of neurons transfected with Neurod2 shRNA or non-targeting shRNA
reveals a significant reduction in Cdk5r1 mRNA levels (p-value = 9.6x10−8) and a trend of reduction in Lrp8 levels (p-value = 0.18) after Neurod2
knockdown. All RT-qPCR results represented data from 3 biological samples each analyzed in technical triplicates. Bars represent standard error
of mean
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of expression patterns at mid-embryogenesis revealed
that Neurod2 expression overlapped with the regions
expressing Fezf2, Bcl11b, Cux1 and Satb2 (Allen Devel-
oping Mouse Brain Atlas and Fig. 5a, e, i, and m).
Next, we confirmed NEUROD2 association with the pro-
moter regions of these genes, by NEUROD2 ChIP coupled
with quantitative PCR (Fig. 5c, g, k and o). Our analysis re-
vealed that NEUROD2 associated strongly with the pro-
moter regions of Fezf2, Bcl11b, Cux1 and Satb2 genes. In
order to determine whether NEUROD2 is required for the
expression of cortical layer-specific transcription factors,
we quantified their mRNA levels by RT-qPCR after
Fig. 5 NEUROD2 target genes encode transcription factors that control the differentiation of distinct populations of cortical layer specific projection
neurons. mRNA expression data is obtained from Allen Developing Mouse Brain Atlas (http://developingmouse.brain-map.org) for Fezf2 (a), Bcl11b (e),
Cux1 (i) and Satb2 (m) for E15.5 mouse brain. Neurod2 expression overlaps with the domains expressing each of the cortical layer specific transcription
factors. (b, f, j and n) NEUROD2 peaks are plotted relative to enhancer (H3K4me1) and promoter (H3K4me3) marks. H3K4me1 and H3K4me3 ChIP-Seq
data is from (www.encodeproject.org) [31]. Peaks are plotted using the genome browser at genome.ucsc.edu. (c, g, k and o) NEUROD2 ChIP followed by
qPCR confirms NEUROD2 binding to the promoter regions of all four layer markers relative to a negative control (GFP ChIP) (p-value < 0.05). Data is
normalized to the amount of input DNA as described in the Methods section. Bars represent standard error of mean. Data represents two biological and five
technical replicates. (d, h, l and p) mRNA levels of Fezf2, Bcl11b, Cux1 and Satb2 were quantified by RT-qPCR in neurons transfected with either a
non-targeting or a Neurod2 shRNA. A significant reduction in Cux1 mRNA levels was observed in the absence of NEUROD2. Each experiment represents 3
biological samples each analyzed in technical triplicates. Data is presented as fold change of control sample (* p-value = 0.0014). p-values for changes in
expression of Fezf2, Bcl11b and Satb2 were between 0.1 and 0.2. A non-targeting shRNA was used as control. Bars are standard error of the mean
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Neurod2 knockdown in primary cortical neurons (Fig. 5d,
h, l, and p). Interestingly, we observed a general trend in
which all four transcription factor levels were reduced, al-
beit at varying levels of significance. In particular, the ex-
pression of Cux1 mRNA was very significantly decreased
by approximately 60 %. Together, our results argue that
NEUROD2 is a principal regulator of a group of tran-
scription factors that confer layer-specific identities to
cortical projection neurons.
Given that a major function of layer-specific transcrip-
tion factors during cortical development is to express
the correct set of axon guidance receptors and establish
proper connectivity, next we focused on how NEUROD2
might be involved in this process. Evidence supporting
this possibility comes from a study demonstrating that
Neurod2 genetically interacts with another bHLH neur-
onal differentiation factor, Neurod6, to establish the cor-
pus callosum and the anterior commissure fiber tract
[11]. These axon guidance defects have been correlated
with dysregulation of the cell adhesion protein Cntn2
and the axonal receptor Robo1 in Neurod2/6 double
knockout mice [11]. To our knowledge no other study
has investigated a role for NEUROD2 in fasciculation
and guidance of cortical projection neuron axons. Con-
sequently, the full extent of the NEUROD2 regulated
axon guidance pathways is unknown.
Our previous pathway analysis using the Biocarta data-
base identified the Reelin signaling pathway as a primary
target of NEUROD2, however did not reveal any sugges-
tions of NEUROD2 regulation of cortical neuronal con-
nectivity. Since different pathway databases have the
potential to illuminate different aspects of a given gene
set, to further explore NEUROD2 controlled pathways
we compared our set of target genes against the KEGG
(Kyoto Encyclopedia of Genes and Genomes) pathway
database using David Bioinformatics Resources [39, 40].
Interestingly, our pathway analysis revealed axon guid-
ance as the most significantly targeted pathway (p-value:
4.2 × 10−13) (Additional file 6). Among the 132 genes
which construct different axon guidance pathways in the
KEGG database, 30 were targets of NEUROD2 (Table 2
and Additional file 8). In particular, we observed an en-
richment for genes that constitute the Ephrin/Eph Re-
ceptor, Semaphorin/Plexin Receptor and Slit/Robo
Receptor signaling pathways. Our results are consistent
with a role for NEUROD2 in callosal axon guidance and
in formation of commissural fiber tracts via direct expres-
sion of receptors or ligands mediating axon repulsion and
attraction during the mid-embryogenic period.
In this study, we have identified the in vivo targets of
NEUROD2, an effector transcription factor during the
peak of cortical excitatory neurogenesis in mice. We
have generated our NEUROD2 target gene dataset by
carrying out a ChIP-Seq analysis on the cortex region of
E14.5 stage mouse embryos. We discovered an enrich-
ment of NEUROD2 binding locations at TSSs. However,
we also observed that many binding sites were distant to
TSSs and overlapped with enhancer regions. Our obser-
vations were in agreement with recent evidence suggest-
ing that TSS-distal transcription factor binding sites are
critical regulators of cell-type specific gene expression
programs [41–44]. Therefore, to assign binding locations
to individual genes, we utilized the ClosestGene method
in order to capture the TSS-proximal and –distal peaks.
Following our computational analysis we predicted 1,045
NEUROD2 target genes and verified a selected subset at
a high rate of confirmation (10/11).
We found that NEUROD2 gene targets include critical
regulators of radial migration of cortical neurons from
the ventricular and subventricular zones to the cortical
plate. A precisely regulated migration process in the de-
veloping cortex is essential for the establishment of a
six-layered cortex. Molecularly, cortical radial migration
requires REELIN, a glycosylated extracellular protein
that is secreted by the Cajal-Retzius cells located in the
most superficial marginal zone of the developing cortex.
Table 2 Top ten axon guidance genes targeted by NEUROD2
Gene symbol Gene name Ensembl ID Normalized ClosestGene score
Epha3 Eph receptor A3 ENSMUST00000064405 52.6
Plxna4 Plexin A4 ENSMUST00000115096 51.8
Slit1 Slit homolog 1 ENSMUST00000025993 48.8
Plxna2 Plexin A2 ENSMUST00000027952 46.9
Sema5b Semaphorin 5B ENSMUST00000120756 42.3
Epha4 Eph receptor A4 ENSMUST00000027451 39.9
Nfatc2 Nuclear factor of activated T-cells ENSMUST00000109184 39.6
Robo2 Roundabout homolog 2 ENSMUST00000023600 36.1
Unc5a Unc-5 homolog A ENSMUST00000109994 34.7
Robo1 Roundabout homolog 1 ENSMUST00000023600 33.0
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Reelin binds to LRP8 (ApoER2) and VLDLR receptors
that are expressed by migrating cortical neurons and by
doing so activates downstream signaling pathways that
eventually reorganize the cytoskeleton and promote mi-
gration [1, 45]. Our data revealed that NEUROD2 binds to
Lrp8 gene at regions overlapping with promoter and en-
hancer specific histone markers and also possibly regulates
its expression. Other essential regulators of cortical radial
migration are the serine-threonine kinase CDK5 (cyclin
dependent kinase 5) and its regulatory subunit CDK5R1
(p35). Loss-of-function mutations of both CDK5 and
CDK5R1 result in impaired radial migration and abnormal
cortical lamination [1, 46, 47]. Intriguingly, we demon-
strated that NEUROD2 binds to and regulates the expres-
sion of Cdk5r1 gene in cortical neurons. To date, a direct
functional role for NEUROD2 in cortical migration has
not been tested. However, consistent with our findings, a
recent study reports abnormal laminar positioning of cor-
tical projection neurons in Neurod2 knockout mice [11].
Looking forward we are greatly interested in directly test-
ing a role for NEUROD2 in the cortical migration process.
Consistent with our gene ontology results we showed
that NEUROD2 was expressed in the neurons of the
SVZ and IZ, which are zones of migrating neurons. Fur-
ther, overlaying our dataset with a study describing dif-
ferentially expressed genes in functionally distinct zones
of the embryonic cortex revealed that NEUROD2 is as-
sociated with approximately 35 % of all genes enriched
in the SVZ and IZ [33]. Many of these genes have not
been investigated with regard to their functions in radial
migration, and are highly likely to have essential roles in
this process as they encode proteins that organize the
neuronal cytoskeleton and control cellular adhesion. We
also observed a number of genes that regulate axonal
pathfinding within this overlapping dataset, including
Epha3, Plxna2 and Robo2, which might indicate add-
itional roles for these receptors in migration, as it has
been recently suggested [48–51]. In sum, our study is in
agreement with a model in which NEUROD2 expression
is initiated in post-mitotic cortical neurons and regulates
their migration through the transcription of a set of
genes controlling actin and microtubule dynamics and
cell surface molecules with roles in cellular adhesion.
Finally, our data suggested that in addition to regulat-
ing the migration of cortical projection neurons, NEU-
ROD2 also targets transcription factors that control the
layer-specific identities and connectivity patterns of neu-
rons located in different layers. In particular, we pro-
vided evidence that NEUROD2 controls both deep-layer
markers, such as Fezf2 and Bcl11b (Ctip2), as well as
upper-layer markers such as Satb2 and Cux1. In sum-
mary, our dataset offers an exciting list of genes and
pathways with putative roles in migration, layer-specific
differentiation and axonal migration.
Conclusions
Significant progress in recent years has identified critical
transcription factors which specify progenitors to the
cortical projection neuron fate. However, little is known
about the effector programs that further control the dif-
ferentiation of this important neuronal subtype [3, 15].
In this study, we report genome-wide targets of an ef-
fector transcription factor, NEUROD2, using a ChIP-Seq
approach. Our results demonstrate that in mice at mid-
embryogenesis (E14.5), a time point which overlaps with
the peak of cortical excitatory neurogenesis, NEUROD2
binds to a set of genes whose functions coalesce into
two essential processes; radial migration and axon guid-
ance. Prominently, we verify that expression of Cdk5r1,
a critical regulator of radial migration, and Cux1, a tran-
scription factor which controls the differentiation of
upper layer (II/III and IV) projection neurons [52–54] is
dependent on NEUROD2. Our study highlights the
value of ChIP-Seq experiments conducted within rele-
vant tissue and during a developmental period [16] and
offers the potential of unveiling novel genes and pathways
regulating cortical projection neuron differentiation.
NEUROD2 controls the differentiation and physiology
of a variety of different types of neurons such as those
located in the hippocampus, amygdala and cerebellum.
Looking forward, it is of interest to identify NEUROD2
targets in the context of different spatiotemporal settings
within the developing nervous system.
Methods
Chromatin immunoprecipitation (ChIP) and sequencing
Mouse embryonic day 14.5 cortices were dissected in
ice-cold 1x HBSS containing 100 mM HEPES. For each
ChIP-Seq experiment 30 embryos derived from 5 preg-
nant mothers were used. After dissection, tissue was trit-
urated once in 1x HBSS and cross-linked for 10 min. in
1 % formaldehyde. Cross-linking was quenched by
addition of glycine to 125 mM final concentration for
10 min. Tissue was lysed in cold RIPA buffer (0.05 M
Tris–HCl pH 7.5, 0.15 M NaCl, 1 % Triton-X 100, 1 %
Na-DOC, 0.1 % SDS) containing freshly added protease
inhibitors and sonicated using a Bandelin Sonoplus
HD2070 sonicator for 30 times at 70 % output for 20 s
in the cold-room. Pellets was discarded after a 20 min.
4 °C centrifugation step at 14,000 rpm. Lysates was pre-
cleared in Protein A/G magnetic beads (Pierce, cat.
88803). 10 % of the pre-cleared lysate was set aside as
input control. Pre-cleared lysates were transferred to
fresh eppendorfs and incubated with Protein A/G beads
and ChIP antibodies (NEUROD2 antibodies are from
Abcam, cat. ab104430, ab109406, ab168932; GFP anti-
bodies are from Santa Cruz, cat. sc-8334, and Pierce, cat.
4B10B2). All antibodies were used at a 10 μg/ml final
concentration. After antibody incubations beads were
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washed with seven different wash buffers twice for 10 mi-
nutes. (Buffer 1: 1X PBS, 0.1 % SDS, 0.5 % Na-DOC,
0.5 % NP-40; Buffer 2: 5X PBS, 0.1 % SDS, 0.5 % Na-
DOC, 0.5 % NP-40; Buffer 3: 15 mM Tris–HCl, pH 7.5,
5 mM EDTA, 2.5 mM EGTA, 1 % Triton X-100, 1 %
Na-DOC, 0.1 % SDS, 120 mM NaCl, 25 mM KCl; Buffer
4: 15 mM Tris–HCl, pH 7.5, 5 mM EDTA, 2.5 mM EGTA,
1 % Triton X-100, 1 % Na-DOC, 0.1 % SDS, 1 M NaCl;
Buffer 5: 15 mM Tris–HCl, pH 7.5, 5 mM EDTA; Buffer 6:
50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM MgCl2,
0.05 % NP-40; Buffer 7: 50 mM Tris–HCl, pH 7.5, 10 mM
MgCl2, 0.5 % NP-40). ChIP DNA was eluted in 300 μl elu-
tion buffer 1 (1 % SDS, 0.1 M NaHCO3) at 65 °C for an
hour. Beads were discarded and the eluate was incubated
for an additional 12–15 h at 65 °C. Equal volume of elution
buffer 2 (100 mM Tris–HCl, 20 mM EDTA pH 8.0) and
1 μl of RNAse A (Thermo Scientific, cat. R1253) was
added and incubated at 37 °C for 1 h. Then, 4 μl of
Proteinase K (Thermo Scientific, cat. EO0491) was added
and incubated at 50 °C for 2 h. ChIP DNA was purified by
standard phenol-chloroform extraction followed by etha-
nol precipitation. Finally, library preparation and 50 bp
single end sequencing (Solexa HiSeq 2500 platform)
services were performed at Genewiz, Inc., USA.
Data access
The data from this study were submitted to Gene Ex-
pression Omnibus (GEO) under the accession number
[GEO:GSE67539].
ChIP and qPCR of NEUROD2 binding sites
Ten percent of the lysate used for a single ChIP experi-
ment was set aside as input. Using this input, chromatin
DNA was prepared by standard phenol-chloroform ex-
traction and ethanol precipitation. Input (input DNA)
and chromatin immunoprecipitated DNA (ChIP DNA)
were each dissolved in 300 μl water and 1 μl of each was
used in a single qPCR reaction. The numerical value
3.32 (log210, representing 10 % of input chromatin) was
subtracted from the Ct value of the input sample to gener-
ate the adjusted input Ct. Following formula was used to
calculate the input normalized chromatin immunoprecipi-
tated DNA amount: 100 × 2(Adjusted input Ct – ChIP Ct). ChIP
DNA was prepared using NEUROD2 antibody 2 and
negative control ChIP DNA by using GFP antibody 2
for all qPCR experiments (see Additional file 2). Primer
sequences are provided in Additional file 9.
Neurod2 knockdown in primary cortical neurons
An shRNA targeting Neurod2 was cloned into pSUPER-
neo-GFP backbone vector as described in oligoengine.
com. Oligos used for cloning are provided in Additional
file 9. Primary cortical neuronal cultures were prepared
from E14.5 pups. shRNA encoding plasmids were
transfected into primary cortical neurons immediately
before plating by nucleofection (P3 primary cell 4-D
nucleofector X kit, Lonza, program no: CU-133). After
plating, transfected neurons were cultured for 4 days in
vitro before harvesting. For western blotting cells were
lysed in ice-cold RIPA buffer. For total RNA isolation
cells were lysed in Trizol (Thermo Scientific, Inc.).
Reverse transcription and qPCR of NEUROD2 target genes
Ten nanogram total RNA was used to prepare cDNA
from Neurod2 knockdown and non-targeting samples
(Transcriptor high-fidelity cDNA synthesis kit, Roche).
mRNA levels were quantified by qPCR analysis (Luminaris
Color Higreen qPCR Master Mix, Thermo Scientific)
with primers listed in Additional file 9 (CFX Connect
Real-Time PCR Detection System, BioRad).
Identification of NEUROD2 peaks
Peak calling was performed using tools available on Gal-
axy Project (usegalaxy.org). Tool names and versions are
indicated below. Single end 50 bp raw sequences in fastq
format were mapped onto the mouse genome (mm10
build) with Bowtie for Illumina (version 1.1.2) [17, 18].
Two mismatches were allowed within a 28 nt seed re-
gion. PCR duplicates with identical start and end points
were removed and collapsed onto a single read with
rmdup (version 1.0.0). Reads that mapped onto multiple
locations on the genome were removed with Filter SAM
(version 1.0.0). Peaks locations were identified with
MACS (Model-based analysis of ChIP-Seq version 1.0.1)
[19]. 50 nt tag size, 200 nt band width, 1 × 10−5 p-value
cutoff and an MFOLD high confidence enrichment ratio
of 20 were used as input parameters. Results from ChIP
performed using GFP antibodies were used as ChIP-Seq
control files for MACS analysis. GFP ChIP reads gener-
ated with a rabbit antibody (Santa Cruz cat. sc-8334)
were used as input controls for NEUROD2 ChIP reads
generated with rabbit antibodies (Abcam cat. ab104430
and ab109406). GFP ChIP reads generated with a mouse
antibody (Pierce, cat. 4B10B2) were used as input con-
trols for NEUROD2 ChIP reads generated with a mouse
antibody (Abcam cat. ab168932). The antibody informa-
tion is presented in Additional file 2.
Bioinformatics analysis of peak sequences
MACS outputs from ChIP-Seq data using different
NEUROD2 antibodies were combined to yield a single
set of high-confidence peak locations. To this end, we
first eliminated isolated instances where a MACS peak
from an antibody has no overlap with those derived
from the other two antibodies. Remaining overlapping
peaks were next merged to yield a single set of 32,367
peak regions which, by construction, are confirmed by at
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least two experiments. The midpoint of each peak was
used as the peak location.
The statistical analysis of peak locations was done on
the genome assembly GRCm38/mm10 with Ensembl an-
notations for coding and noncoding regions CDS, 5′
UTRs, 3′UTRs, and introns [24, 55]. In order to prevent
double counting due to multiple transcripts per gene
in the Ensembl database, the longest transcript was se-
lected as representative of each gene. All numerical
analyses were performed by means of custom Perl
scripts using the Bioperl module for efficiency.
Binding preference of NEUROD2 to different types of
intragenic regions was investigated by comparing the ob-
served peak count n for a given region type with the cor-
responding mean n and standard deviation σ, both of
which were obtained from a uniformly random reassign-
ment of the observed intragenic peaks to transcript regions
genome-wide. We measured the binding preference in
terms of the deviation of the observed peak count from the
random expectation, where the deviation was expressed in
multiples of the standard deviation, i.e., bp ¼ n−nð Þ=σ:
Affinity of NEUROD2 for binding specifically in the
proximity of transcription start sites (TSSs) was investi-
gated by considering all peak/TSS pairs located up to
106 bps apart and constructing the corresponding peak-
TSS distance histogram.
NEUROD2 consensus sequence was determined by
using MEME ChIP Suite using 32,367 NEUROD2 peak se-
quences as input. Accession numbers for data downloaded
from Encode Project (encodeproject.org) were: For E14.5
whole brain ChIP using antibodies against, H3K4me1
(ENCSR000CCZ), H3K4me3 (ENCSR000CDA) and CTCF
(ENCSR000CEH) [31]. All data downloaded from Encode
Project were generated by the Bing Ren Laboratory, UCSD.
Gene ontology analysis was performed as described in [56].
Target gene identification
Individual peaks were assigned to genes using the Clo-
sestGene method as described in [29]. Briefly, each of the
32,367 NEUROD2 peaks was assigned to the closest
transcription start site belonging to a specific gene and
received a positive score that decreased with the distance
from the assigned TSS. Each gene received a cumulative
ClosestGene target score which was the sum of the
scores of all associated peaks. As a background control
32,367 randomly distributed peaks along the mouse
genome were assigned to specific genes using the same
method.
Use of animals
All mice were bred and housed at Koç University Animal
Research Laboratory. Timed pregnant BALB/c strain mice
at E14.5 stage were sacrificed by cervical dislocation, and
embryos were retrieved into ice-cold 1x HBSS for cortical
dissection. All animal experiments were done in accord-
ance with guidelines provided by the Koç University, The
Turkish Ministries of Food, Agriculture and Live Stock,
Forestry and Water Management and the European Union.
Ethics approval was obtained from The Koç University In-
stitutional Animal Care and Use Committee (no. 2013–1).
Additional files
Additional file 1: In this file we provide raw data for characterization
of antibodies used for NEUROD2 ChIP-Seq experiments. In order to test
for antibodies that work well in the immunoprecipitation (IP) technique, we
over-expressed myc-tagged NEUROD2 in Neuro2A cell line, immunoprecipi-
tated with one of three different NEUROD2 antibodies, and immunoblotted
(IB) with a myc antibody. All three antibodies robustly immunoprecipitated
overexpressed NEUROD2. s/n: supernatant. (PDF 128 kb)
Additional file 2: In this file we provide the raw sequencing counts
and number of peaks for each ChIP-Seq experiment with individual
antibodies used in this study. (XLSX 7 kb)
Additional file 3: In this file we list the genome-wide in vivo
NEUROD2 peak coordinates. (XLSX 3195 kb)
Additional file 4: In this file we list the genome-wide in vivo
NEUROD2 target genes. (XLSX 799 kb)
Additional file 5: Confirmation of NEUROD2 binding to putative
target genes identified by the ClosesetGene method. NEUROD2 ChIP
and GFP ChIP DNA were used as templates for qPCR analysis. Data is
represented as the amount of enrichment in target genes in NEUROD2
ChIP DNA as compared to a negative control GFP ChIP DNA. NEUROD2
non-target genes did not display a significant level of NEUROD2 binding.
(XLSX 9 kb)
Additional file 6: In this file we provide the list of most
significantly represented pathways among NEUROD2 target
genes (http://david.abcc.ncifcrf.gov/home.jsp). (XLSX 7 kb)
Additional file 7: In this table we provide the NEUROD2 target
genes that are differentially expressed in the SVZ-IZ region. (XLSX 10 kb)
Additional file 8: In this table we provide the NEUROD2 target
genes that function in axon guidance pathways. (XLSX 11 kb)
Additional file 9: This table lists the sequences of all primers used
in this study. (XLSX 9 kb)
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